Randomised placebo-controlled, double-blind, exploratory trial of Bosentan for Steroid-resistant Pulmonary Sarcoidosis: the BOSSA Study

Trial Profile

Randomised placebo-controlled, double-blind, exploratory trial of Bosentan for Steroid-resistant Pulmonary Sarcoidosis: the BOSSA Study

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Nov 2014

At a glance

  • Drugs Bosentan (Primary)
  • Indications Pulmonary sarcoidosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms BOSSA
  • Sponsors Actelion Pharmaceuticals
  • Most Recent Events

    • 16 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top